logo
Share SHARE
FONT-SIZE Plus   Neg

Bouygues Unit Agrees To Buy UK's Thomas Vale - Update

French construction giant Bouygues SA (BOUYY.PK) said Tuesday that its subsidiary Bouygues Bâtiment International has signed an agreement to acquire 100 per cent of U.K. contractor Thomas Vale Group.

Thomas Vale specialises in new build and refurbishment in the public and private
arenas including retail, office and leisure sectors. The company has a proven track record in housing
and regeneration through its long-term public sector partnerships.

The company has a well-established client base across central England, Bouygues added. It has won the Construction News 'Judge's Supreme Award' three times in recent years.

Worcestershire-based Thomas Vale expects to generate sales of over 200 million pounds for fiscal 2012. Established in 1869, it employs over 700 people.

The deal is significant for Bouygues Construction's expansion program in the UK, providing it with access to a geographical region that complements the group's existing subsidiaries in London, the South East, South West and Wales.

Bouygues Construction began operating in the UK around 15 years ago and operates several Private Finance Initiative contracts. The Group acquired Warings in December 2007 and the Leadbitter Group in early 2011.

Bouygues closed in Paris on Tuesday lower by 3.72 percent at 20.79 euros on a volume of 1.79 million shares.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Seafood lovers must now be prepared to dole out more cash than before for salmon. The price of salmon has surged globally and is now at historic highs amid acute outbreaks of sea lice. According to data from the Nasdaq Salmon Index, the price of salmon has risen by more than 15 percent in the last three months. Health-food restaurant chain Freshii Inc. has increased the price range for its initial public offering in Canada. Freshii has raised the price range for its IPO to C$10 to C$11.50 per share from the prior range of C$8.50 to C$10.0 per share, BNN reported. Drug major Johnson & Johnson Tuesday said it expects higher earnings and sales for its fiscal 2017, which are below market estimates. The company also reported solid fourth-quarter results, with adjusted earnings above market estimates, while sales missed their view, despite a growth. In pre-market activity on the NYSE, Johnson & Johnson shares were losing 1.68 percent.
comments powered by Disqus
Follow RTT